7 Ways to Ease the Pain of Diagnostic Test Access and Reimbursement

Access to diagnostic tests and the subsequent reimbursement is an issue affecting all stakeholders in the fast evolving personalized medicine space. It’s an intricate web woven by drug companies, payers, insurance giants, laboratories and national health organizations. And once you think you have it sorted, you’re likely to face continuing adjustments and new considerations on […]

Why Financial Analysts in Pharma Should Love Personalized Medicine

Financial analysts have good reason to anticipate the continued growth of personalized medicine. Not only is it affecting patients and physicians but it holds plenty of promise for the pharma industry. General Strategic Development Benefits Personalized medicine encourages more vertical collaboration throughout the industry. It is therefore in the best interest of pharma companies to […]